Peptide foldamer-based inhibitors of the SARS-CoV-2 S protein-human ACE2 interaction
Description
The entry of the SARS-CoV-2 virus into a human host cell begins with the interaction between the viral spike protein (S protein) and human angiotensin-converting enzyme 2 (hACE2). Therefore, a possible strategy for the treatment of this infection is
